Bookmark and Share

BioActivity Data for Compound 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide (CID 6918454)

BioActivity Outcomes:
Active(515)
 
 
Inactive(76)
 
 
Inconclusive(48)
 
 
Unspecified(677)
 
 
Top Targets:
PTKc Abl(16)
 
 
PKc like(13)
 
 
PTKc EGFR(12)
 
 
PI3Kc IA alph..(10)
 
 
STKc RSK N(10)
 
 
 
BioAssay Types:
Confirmatory(678)
 
 
 
 
 
Literature(587)
 
 
 
 
Summary(28)
 
 
 
 
Screening(15)
 
 
 
BioAssay Categories:
In vitro(1028)
 
 
 
In vivo(6)
 
 
Biochemical(551)
 
 
 
 
Toxicity(10)
 
 
 
 
 
ADME(6)
 
 
Cell-based(635)
 
 
 
 
BioActivity Types:
IC50(601)
 
 
 
 
Kd(442)
 
 
 
Potency(107)
 
 
 
 
AC50(6)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 1306    Data Row: 1316   Total Pages: 66   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID170466835]
IC50 0.00179HCT116 viability from Cell TiterGlo-IC50 [AID1117332, Type: confirmatory]
View
2
[SID103320975]
IC50 0.002Inhibitory concentration against Mitogen activated protein kinase kinase kinase 1 was determined using Raf/MEK1 coupled assay [AID126772, Type: Literature]
View
3
[SID103320975]
IC50 0.0023Inhibition of MEK-mediated phosphorylation of myelin basic protein by kinase cascade assay [AID410377, Type: Literature]
View
4
[SID103320975]
IC50 0.00245Inhibition of MEK-mediated ERK phosphorylation in PDGF-stimulated mouse K-Balb cells treated as single oral dose preincubated for 1 hr before PDGF challenge by whole cell assay [AID410378, Type: Literature]
View
5
[SID170466835]
IC50 0.00319RKO viability from Cell TiterGlo-IC50 [AID1117322, Type: confirmatory]
View
6
[SID103320975]
IC50 0.0035Inhibition of MEK-stimulated ERK phosphorylation in PDGF-stimulated mouse C26 cells treated as single oral dose before PDGF challenge by whole cell assay [AID410380, Type: Literature]
View
7
[SID170466835]
IC50 0.00495SW480 viability from Cell TiterGlo-IC50 [AID1117338, Type: confirmatory]
View
8
[SID103320975]
IC50 0.012Inhibition of Raf1 kinase [AID322453, Type: Literature]
View
9
[SID103320975]
IC50 0.016Inhibition of MEK assessed as inhibition of ERK phosphorylation by Raf-MEK-ERK cascade assay [AID298460, Type: Literature]
View
10
[SID170466835]
IC50 0.0171SNU-C1 viability from Cell TiterGlo-IC50 [AID1117323, Type: confirmatory]
View
11
[SID103320975]
IC50 0.02276SANGER: Inhibition of human H9 cell growth in a cell viability assay. [AID742187, Type: confirmatory]
View
12
[SID170466835]
IC50 0.02634HT-29 viability from Cell TiterGlo-IC50 [AID1117330, Type: confirmatory]
View
13
[SID103320975]
IC50 0.02885SANGER: Inhibition of human CHP-212 cell growth in a cell viability assay. [AID742065, Type: confirmatory]
View
14
[SID103320975]
IC50 0.0354Inhibition of MEK-mediated ERK phosphorylation in PDGF-stimulated mouse K-Balb cells treated as single oral dose preincubated for 24 hrs before PDGF challenge by whole cell assay [AID410379, Type: Literature]
View
15
[SID103320975]
IC50 0.04152SANGER: Inhibition of human EoL-1-cell cell growth in a cell viability assay. [AID742166, Type: confirmatory]
View
16
[SID103320975]
IC50 0.046Inhibition of MEK in mouse colon 26 carcinoma cells assessed as inhibition of ERK phosphorylation by ELISA [AID298461, Type: Literature]
View
17
[SID103320975]
IC50 0.053Inhibition of MEK in mouse Colon 26 cells by Western blot [AID345052, Type: Literature]
View
18
[SID103320975]
IC50 0.07599SANGER: Inhibition of human DU-4475 cell growth in a cell viability assay. [AID742125, Type: confirmatory]
View
19
[SID103320975]
IC50 0.10974SANGER: Inhibition of human MMAC-SF cell growth in a cell viability assay. [AID742370, Type: confirmatory]
View
20
[SID103320975]
IC50 0.11713SANGER: Inhibition of human AGS cell growth in a cell viability assay. [AID741960, Type: confirmatory]
View